FEops closes € 6 million Series B financing

Ghent, Belgium: 22 September 2017 - FEops, a leader in personalized computer modeling for structural heart interventions, announced it has secured a 6 million euros investment, led by Valiance, and joined by existing investors Capricorn and PMV. The funding will be used to aggressively implement the company's product roadmap, centered around FEops HEARTguideTM, and drive commercial adoption in the fastgrowing market for transcatheter valve therapies.

FEops HEARTguideTM proprietary array of products use advanced computer simulations to provide clinicians and valve manufacturers first-ever insights into the interaction between valve and specific patient anatomy - preoperatively. Such insights have tremendous power to accelerate research and development of novel valve-based solutions, as well as ultimately improve clinical outcomes in real-world hospital settings.

More info on FEops' website.


Next > FRX Polymers enables new high-impact strength, V-0 flame retardant, chemical-resistant thermoplastic compound from Polyvisions

Previous > FRX Polymers Announces Availability of Nofia® Non-Halogenated Flame Retardants as Replacement for Antimony in Brominated Systems